.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Delivery within India

Delivery outside India

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Magazine
Markets
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Start-Up
Planet
Others
- Spotlight

Budget 2026
Magazine
Markets
OB Datalens
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Start-Up
Planet
Tech
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

Magazine
Markets
Corporate
Economy & Policy
Newsletters
News
AI
Start-Up
Planet
Others

home
Topic
Cloudnine

Cloudnine

Cloudnine Hospitals : Cloudnine

Global PE Giants Eye Cloudnine's ₹11,000 Cr Stake Sale

BY Outlook Business Desk

AI Generated Image

Why Global PE Investors Are Betting Big On India’s Hospital Sector

Cloudnine Hospitals : Cloudnine

Warburg, KKR, TPG Among Suitors for Cloudnine Stake as True North Plans Exit

BY Outlook Business Desk

Temaseks X (formerly Twitter) : Temasek Holdings

Temasek Holdings Poised to Acquire Peak XV's Stake in Cloudnine Hospitals

BY Outlook Start-Up Desk

The company is looking to raise around Rs 1,200 crore through the IPO.

Cloudnine Files Draft Papers With SEBI; Eyes Rs 1,200 Crore Via IPO

BY PTI

Close Ad

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2026 Outlook Publishing India Pvt Ltd.

Copyright © 2026 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.